Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 16NIH 5NETWORK 2INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 23Lymphoid 5Myeloid 2Dermatologic 2Thoracic 1Other solid neoplasm 1Other neoplasm 1Genitourinary 1CNS 1

Conditions

Melanoma 2

Interventions

Interferon-alpha 6Radiosurgery 4Dacarbazine 4encorafenib 3binimetinib 3aldesleukin 3Radiotherapy 3Methotrexate 3Immunohistochemistry 3Gene Expression Profiling 3Filgrastim 3Etoposide 3Cyclophosphamide 3Cisplatin 3Watchful Waiting 2Vincristine 2Vinblastine 2Temozolomide 2Polymerase Chain Reaction 2Nivolumab 2Ipilimumab 2Introns 2Interferon alpha-2 2Immunologic Techniques 2Flow Cytometry 2Carboplatin 2trametinib 1tebentafusp 1sulforaphane 1sargramostim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Flow Cytometry × Dermatologic × Clear all
NCT01388569 2017-05-17

Biomarkers in Blood Samples From Patients With Stage IV Melanoma Previously Treated With Sargramostim

Eastern Cooperative Oncology Group

Completed
48 enrolled
Dermatologic

Melanoma

NCT01489423 2017-05-17

Tissue and Blood Biomarkers From Patients With Stage III or Stage IV Melanoma Treated With Ipilimumab With or Without Sargramostim

Eastern Cooperative Oncology Group

Completed
270 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡